This inventor holds 1 USPTO granted patent. Top assignees: Fasgen, Inc., Johns Hopkins University. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2012
Title: The Innovative Contributions of Louise D McCullough
Introduction
Louise D McCullough is a prominent inventor based in Baltimore, MD, known for her significant contributions to the field of neuroprotection. With a focus on innovative methods to protect the brain during critical medical events, her work has the potential to transform treatment approaches for stroke and degenerative diseases.
Latest Patents
McCullough holds a patent for a groundbreaking method of neuroprotection through the pharmacological inhibition of AMP-activated protein kinase. This method involves administering an AMPK inhibitor to patients who are experiencing or have experienced a stroke. The use of these compounds significantly reduces the size of infarcts, thereby minimizing the loss of brain tissue and neurons. As a result, the preservation of brain function after stroke or ischemic injury is achievable. Additionally, her research indicates that neuronal loss can be mitigated in degenerative diseases that disrupt energy utilization and availability in neurons.
Career Highlights
Throughout her career, McCullough has worked with notable organizations, including Fasgen, Inc. and The Johns Hopkins University. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in neuroprotective strategies.
Collaborations
Some of her notable coworkers include Jill Marie Sturdivant and Gabriele V Ronnett. Their collaborative efforts have further enhanced the impact of McCullough's research and innovations.
Conclusion
Louise D McCullough's work in neuroprotection exemplifies the vital role of inventors in advancing medical science. Her innovative methods and collaborations continue to pave the way for improved treatments for stroke and neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile